BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7011468)

  • 1. Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie RG; Dingwall JM; Wiles DH; Heykants JJ
    Br J Psychiatry; 1980 Dec; 137():510-7. PubMed ID: 7011468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie R; Mackie M; Morrison D; Kidd J
    Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 Feb; 8(1):59-70. PubMed ID: 345313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
    Abuzzahab FS; Zimmermann RL
    Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675
    [No Abstract]   [Full Text] [Related]  

  • 5. Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
    McKane JP; Robinson AD; Wiles DH; McCreadie RG; Stirling GS
    Br J Psychiatry; 1987 Sep; 151():333-6. PubMed ID: 3322467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medico-social evaluation of the long-term pharmacotherapy of schizophrenia. Comparative study of fluphenazine and pimozide.
    Shepherd M
    Prog Neuropsychopharmacol; 1979; 3(4):383-9. PubMed ID: 401349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pimozide versus fluphenazine in ambulatory schizophrenics: A 12-month comparison study.
    Donlon PT; Swaback DO; Osborne ML
    Dis Nerv Syst; 1977 Feb; 38(2):119-23. PubMed ID: 319967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity in chronic schizophrenic patients: comparison of pimozide with fluphenazine in a double blind trial.
    Sims AC; Burnside IG
    Psychol Med; 1975 May; 5(2):161-4. PubMed ID: 1099598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia.
    Abuzzahab FS; Zimmermann RL
    Psychopharmacol Bull; 1976 Apr; 12(2):26-7. PubMed ID: 769023
    [No Abstract]   [Full Text] [Related]  

  • 10. The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 May; 8(2):265-74. PubMed ID: 418431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pimozide as a neuroleptic.
    Freeman H
    Br J Psychiatry; 1979 Jul; 135():82-3. PubMed ID: 497633
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia [proceedings].
    Abuzzahab FS
    Psychopharmacol Bull; 1977 Jan; 13(1):71-3. PubMed ID: 319477
    [No Abstract]   [Full Text] [Related]  

  • 14. The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
    Br J Psychiatry; 1987 Mar; 150():334-8. PubMed ID: 2889495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimozide in the treatment of newly admitted schizophrenic patients.
    Chouinard G; Annable L
    Psychopharmacology (Berl); 1982; 76(1):13-9. PubMed ID: 6805002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
    Inderbitzin LB; Lewine RR; Scheller-Gilkey G; Swofford CD; Egan GJ; Gloersen BA; Vidanagama BP; Waternaux C
    Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.
    Barnes TR; Milavic G; Curson DA; Platt SD
    Soc Psychiatry; 1983; 18(4):193-9. PubMed ID: 6356386
    [No Abstract]   [Full Text] [Related]  

  • 19. Weekly pimozide versus fluphenazine decanoate in schizophrenic out-and day-patients.
    McCreadie RG; McKane JP; Mackie M
    Br J Psychiatry; 1983 Jul; 143():97-8. PubMed ID: 6349740
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
    Russell N; Landmark J; Merskey H; Turpin T
    Can J Psychiatry; 1982 Nov; 27(7):593-6. PubMed ID: 7172160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.